Aclaris Therapeutics Inc. (ACRS) Dipped -5.07% or -0.96 To Price $17.99 On Wednesday


Aclaris Therapeutics Inc. (ACRS) dipped -5.07% or -0.96 to $17.99. It is approximately 162921 shares traded, which is 79.9% compare to the average total volume 203904. The market cap of ACRS is $556.00 million. The year to date change is -24.29%. The 52 week price range is from $16.01 to $30.08. Price of ACRS have changed -0.21% during last week. It have changed 6.76% over last month, -4.96% over last 3 months, -18.39% over last 6 months and -18.95% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ACRS is 18.02. It is 0.17% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for ACRS is 22.36. It is 24.29% above current price. The 52-week High is 30.08. It is 67.20% from the current price. The 52-week Low is 16.01. It is -11.01% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ACRS is 26.97 on 2018-05-15. Short % to float is 18.87%. There are some statistics of ACRS. It is has market cap $556.00 million. The share outstanding is 30.91 million. The average volume is 203904. The revenue is 684000. The gross profit is 231000. The percent of top 15 Institution holding is 93.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ACRS is -44.66%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ACRS is -41.74%.


Tags:

Share this post